Business Description
Silexion Therapeutics Corp
Description
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 26.87 | |||||
| Equity-to-Asset | -2.94 | |||||
| Debt-to-Equity | -0.01 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.48 | |||||
| 9-Day RSI | 36.5 | |||||
| 14-Day RSI | 36.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.27 | |||||
| Quick Ratio | 2.27 | |||||
| Cash Ratio | 2.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -67.75 | |||||
| ROIC % | -567.19 | |||||
| ROC (Joel Greenblatt) % | -1316.74 | |||||
| ROCE % | -86.82 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.77 | |||||
| EV-to-EBITDA | -1.79 | |||||
| EV-to-FCF | -1.82 | |||||
| Earnings Yield (Greenblatt) % | -56.5 | |||||
| FCF Yield % | -46.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLXN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Silexion Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.606 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 36.03 | ||
| 14-Day ATR ($) | 0.283234 | ||
| 20-Day SMA ($) | 1.368353 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.8264 - 4.65 | ||
| Shares Outstanding (Mil) | 9.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Silexion Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Silexion Therapeutics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Silexion Therapeutics Corp Frequently Asked Questions
What is Silexion Therapeutics Corp(SLXN)'s stock price today?
The current price of SLXN is $1.01. The 52 week high of SLXN is $4.65 and 52 week low is $0.83.
When is next earnings date of Silexion Therapeutics Corp(SLXN)?
The next earnings date of Silexion Therapeutics Corp(SLXN) is .
Does Silexion Therapeutics Corp(SLXN) pay dividends? If so, how much?
Silexion Therapeutics Corp(SLXN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers